Home › Funds › Renaissance Technologies › ACET

Renaissance Technologies position in ACET

ADICET BIO INC · Health Care

Latest position (Q2 2026)265.94K sh
Reported value held$2.30M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd

Quarter by quarter

QuarterSharesValueChange
Q3 2021 42.22K $331.00K New
Q2 2022 125.50K $1.83M New
Q4 2022 29.70K $266 New
Q1 2023 315.80K $1.82K Add
Q2 2023 210.40K $511 Reduce
Q3 2023 677.00K $927 Add
Q4 2023 766.60K $1.45K Add
Q1 2024 1.05M $2.46K Add
Q2 2024 1.51M $1.83M Add
Q3 2024 1.23M $1.77M Reduce
Q4 2024 916.50K $881.67K Reduce
Q1 2025 810.70K $612.08K Reduce
Q1 2025 810.70K $612.08K Reduce
Q2 2025 1.15M $703.83K Add
Q2 2025 1.15M $703.83K Add
Q3 2025 1.83M $1.48M Add
Q4 2025 242.94K $2.05M Reduce
Q1 2026 232.59K $1.58M Reduce
Q2 2026 265.94K $2.30M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding ACET

All ACET fund holders →